IMMUPHARMA (LSE:IMM)

 

Latest News

Immupharma completes clinical trial

ImmuPharma PLC (LSE:IMM), the specialist drug discovery and development company, has provided an update on its lea...

CANCER UPDATE: IPP-204106

RNS Number: 6464E Immupharma PLC 11 February 2015 FOR IMMEDIATE RELEASE 11 FEBRUARY 2015 CANCER UPDATE: IPP-204106 ImmuPharma PLC (LSE:IMM) , ("ImmuPharma" or the "Company"), the specialist drug discovery and development company, provides an update on its lead Cancer programme - IPP-204106. As previously stated, the Phase I/...

ImmuPharma gets assurance over EIS

ImmuPharma, the specialist drug discovery and development company, has received advance assurance from HM Revenu...

Enterprise Investment Scheme Status

RNS Number: 1727D Immupharma PLC 27 January 2015 FOR IMMEDIATE RELEASE: FULL RNS 27 JANUARY 2015 IMMUPHARMA Advance Assurance Received from H M Revenue and Customs Regarding "Enterprise Investment Scheme" Status ImmuPharma PLC (AIM: IMM) ("ImmuPharma" or the "Company"), the specialist drug discovery and develo...

All News

DateHeadlineSource
11-02-15Immupharma completes clinical trial StockMarketWire
11-02-15CANCER UPDATE: IPP-204106RNS
27-01-15ImmuPharma gets assurance over EIS StockMarketWire
27-01-15Enterprise Investment Scheme StatusRNS
22-01-15FTSE surges as ECB unveils QE, financials riseStockMarketWire
22-01-15FTSE cautiously up as ECB's QE call nearsStockMarketWire
22-01-15Collaboration Agreement with Simbec-OrionRNS
30-10-14Holding(s) in CompanyRNS
28-10-14Holding(s) in CompanyRNS
21-10-14FTSE 100 makes strong recoveryStockMarketWire
21-10-14FTSE 100 bounces backStockMarketWire
21-10-14ImmuPharma raises £3.4m StockMarketWire
21-10-14Additional Listing - Conditional PlacingRNS
20-10-14ImmuPharma unit awarded €400,000 grant StockMarketWire
20-10-14ImmuPharma awarded EUR400,000 GrantRNS
30-09-14Losses remain at ImmuPharmaStockMarketWire
30-09-14Half Yearly ReportRNS
30-09-14LupuzorT Gears Up To Start Pivotal Phase III trialRNS
27-06-14Immupharma shareholders approve AGM resolutionsStockMarketWire
27-06-14Result of AGMRNS
27-06-14ImmuPharma extends research capabilitiesStockMarketWire
27-06-14Access to pioneering research in Bordeaux FranceRNS
16-06-14ImmuPharma granted new Nucant patents StockMarketWire
16-06-14NEW NUCANT PATENTSRNS
23-05-14Annual Financial ReportRNS
21-05-14ImmuPharma pre-tax losses riseStockMarketWire
21-05-14Preliminary ResultsRNS
06-05-14ImmuPharma gives summary from lupus conference StockMarketWire
06-05-14Dr. Sylviane Muller - Presentation AbstractRNS
23-04-14Lupuzor founder presents at Osaka UniversityStockMarketWire
23-04-14Dr. S Muller, founder of Lupuzor presentation.RNS
11-04-14ImmuPharma Sponsors the 2014 European Lupus ConferRNS
14-10-13Additional ListingRNS
27-09-13ImmuPharma trims operating lossStockMarketWire
27-09-13Half Yearly ReportRNS
13-08-13ImmuPharma gives update on cancer programmeStockMarketWire
13-08-13UPDATE CANCER PROGRAMME IPP-204106RNS
31-07-13FDA GRANTS IMMUPHARMA AMENDED SPARNS
08-07-13ImmuPharma appoints opinion leaders to advisory board StockMarketWire
08-07-13ImmuPharma appoints opinion leaders to advisory board StockMarketWire

RSS feeds

  • Editorial news feed for LSE:IMM Editorial
  • Regulatory news feed for LSE:IMM Regulatory